Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus

Sarah Doernberg1, Bernhard Schaaf, Klaus Dalhoff

  • 1Department of Internal Medicine, Yale University School of Medicine, The Anlyan Center, S525, P.O. Box 208031, 300 Cedar Street, New Haven, CT 06520-8031, USA. sarah.doernberg@ucsf.edu

Cytokine
|January 7, 2011
PubMed

Insights

A specific gene variant for macrophage migration inhibitory factor (MIF) may increase the risk of invasive pneumococcal meningitis. This finding links MIF genotype to severe Streptococcus pneumoniae infections.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Macrophage migration inhibitory factor (MIF) is a key proinflammatory cytokine.
  • MIF is encoded by a gene locus with known functional polymorphisms.
  • Invasive Streptococcus pneumoniae infections pose significant public health challenges.

Purpose of the Study:

  • To investigate the association between macrophage migration inhibitory factor (MIF) gene polymorphisms and the susceptibility to invasive Streptococcus pneumoniae infections.
  • To determine if specific MIF genotypes correlate with the occurrence of pneumococcal meningitis.

Main Methods:

  • Genotyping of the MIF locus in 119 patients.
  • Analysis of the relationship between identified MIF alleles and invasive pneumococcal infection status.
  • Statistical evaluation to assess the significance of observed associations.

Main Results:

  • An association was identified between a high-expression MIF allele and the occurrence of pneumococcal meningitis.
  • The study included 119 patients with invasive Streptococcus pneumoniae infections.

Conclusions:

  • A specific high-expression MIF allele is associated with an increased risk of developing pneumococcal meningitis.
  • MIF genotype may play a role in the pathogenesis of invasive Streptococcus pneumoniae infections.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...